Hankyel Park

Array ( [id] => 7335095 [patent_doc_number] => 20040132162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Chimeric papillomavirus-like particles' [patent_app_type] => new [patent_app_number] => 10/741613 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7672 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132162.pdf [firstpage_image] =>[orig_patent_app_number] => 10741613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206528 [patent_doc_number] => 20040087506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Methods of modulating FabH activity' [patent_app_type] => new [patent_app_number] => 10/668588 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14368 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087506.pdf [firstpage_image] =>[orig_patent_app_number] => 10668588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469967 [patent_doc_number] => 20040121317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'HIV envelopolype peptides' [patent_app_type] => new [patent_app_number] => 10/459121 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19556 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121317.pdf [firstpage_image] =>[orig_patent_app_number] => 10459121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730245 [patent_doc_number] => 20030186435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Methods of modulating FabH activity' [patent_app_type] => new [patent_app_number] => 10/443432 [patent_app_country] => US [patent_app_date] => 2003-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14360 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186435.pdf [firstpage_image] =>[orig_patent_app_number] => 10443432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725133 [patent_doc_number] => 20030207445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Lentiviral vector particles resistant to complement inactivation' [patent_app_type] => new [patent_app_number] => 10/425323 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14544 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207445.pdf [firstpage_image] =>[orig_patent_app_number] => 10425323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710522 [patent_doc_number] => 20030170271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Chimeric papillomavirus-like particles' [patent_app_type] => new [patent_app_number] => 10/405264 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7648 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170271.pdf [firstpage_image] =>[orig_patent_app_number] => 10405264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7359014 [patent_doc_number] => 20040014172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use' [patent_app_type] => new [patent_app_number] => 10/384171 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 21689 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014172.pdf [firstpage_image] =>[orig_patent_app_number] => 10384171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7166994 [patent_doc_number] => 20040077090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating' [patent_app_type] => new [patent_app_number] => 10/383798 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 345208 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077090.pdf [firstpage_image] =>[orig_patent_app_number] => 10383798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1145623 [patent_doc_number] => 06773900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-10 [patent_title] => 'End selection in directed evolution' [patent_app_type] => B2 [patent_app_number] => 10/382283 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 65031 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/773/06773900.pdf [firstpage_image] =>[orig_patent_app_number] => 10382283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1162603 [patent_doc_number] => 06759241 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Adjuvant comprising a lipopolysaccharide antagonist' [patent_app_type] => B1 [patent_app_number] => 10/110072 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24559 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759241.pdf [firstpage_image] =>[orig_patent_app_number] => 10110072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668888 [patent_doc_number] => 20030113872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Vasopermeability-enhancing conjugates' [patent_app_type] => new [patent_app_number] => 10/342426 [patent_app_country] => US [patent_app_date] => 2003-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11985 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113872.pdf [firstpage_image] =>[orig_patent_app_number] => 10342426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1110580 [patent_doc_number] => 06806046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-19 [patent_title] => 'Methods for HIV sequencing and genotyping' [patent_app_type] => B2 [patent_app_number] => 10/335059 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6175 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806046.pdf [firstpage_image] =>[orig_patent_app_number] => 10335059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6643060 [patent_doc_number] => 20030104011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method for the development of an HIV vaccine' [patent_app_type] => new [patent_app_number] => 10/331685 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15148 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104011.pdf [firstpage_image] =>[orig_patent_app_number] => 10331685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846783 [patent_doc_number] => 20030165950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Hapten-carrier conjugates for treating and preventing nicotine addiction' [patent_app_type] => new [patent_app_number] => 10/330676 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12203 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165950.pdf [firstpage_image] =>[orig_patent_app_number] => 10330676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1145734 [patent_doc_number] => 06773915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-10 [patent_title] => 'Retrovirus from the HIV group and its use' [patent_app_type] => B2 [patent_app_number] => 10/326090 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16813 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/773/06773915.pdf [firstpage_image] =>[orig_patent_app_number] => 10326090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014471 [patent_doc_number] => 06893813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy' [patent_app_type] => utility [patent_app_number] => 10/329085 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6550 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/893/06893813.pdf [firstpage_image] =>[orig_patent_app_number] => 10329085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788332 [patent_doc_number] => 20030139571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Sulfated CCR5 peptides for HIV-1 infection' [patent_app_type] => new [patent_app_number] => 10/323314 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27237 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139571.pdf [firstpage_image] =>[orig_patent_app_number] => 10323314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261120 [patent_doc_number] => 06664066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-16 [patent_title] => 'Modified Morbillivirus V proteins' [patent_app_type] => B2 [patent_app_number] => 10/311582 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 11 [patent_no_of_words] => 19384 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664066.pdf [firstpage_image] =>[orig_patent_app_number] => 10311582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851327 [patent_doc_number] => 20030143530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Method for the detection of influenza a/b viruses' [patent_app_type] => new [patent_app_number] => 10/311523 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5702 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143530.pdf [firstpage_image] =>[orig_patent_app_number] => 10311523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1080214 [patent_doc_number] => 06835372 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-28 [patent_title] => 'Compositions comprising an active agent' [patent_app_type] => B2 [patent_app_number] => 10/313343 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14741 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835372.pdf [firstpage_image] =>[orig_patent_app_number] => 10313343 [rel_patent_id] =>[rel_patent_doc_number] =>)